FDA approves Emrosi for rosacea in adults

by

The U.S. Food and Drug Administration has approved Journey Medical’s Emrosi (minocycline hydrochloride) for the treatment of inflammatory rosacea in adults.

Leave A Comment

Your email address will not be published. Required fields are marked *